Cash flows from operating activities: | |
Net income | -10.88M |
Adjustments to reconcile net income to net cash flows from operating activities: | |
Depreciation | 7.64M |
Amortization of intangible assets | 6.11M |
Deferred income taxes | |
Amortization of deferred financing costs | 243K |
Share based compensation | 8.75M |
Change in acquisition related contingencies | |
Change in accrual for unrecognized tax benefits | |
Other, net | |
Changes in operating assets and liabilities: | |
Accounts receivable | 8.05M |
Prepaid expenses and other assets | -618K |
Accounts payable and accrued expenses | -3.43M |
Income taxes receivable/payable | |
Deferred revenue | -493K |
Payments to reduce interest rate hedge agreements | |
Other, net | -123K |
Net cash flows from operating activities | 36.61M |
Cash flows from investing activities: | |
Purchases of fixed assets | |
Purchases of marketable securities | |
Maturities and sales of marketable securities | |
Payments for acquisitions | |
Net cash flows from investing activities | -6.03M |
Cash flows from financing activities: | |
Payments on long-term debt | -26M |
Proceeds from long-term debt | 17M |
Proceeds from sale of common stock | |
Purchase of treasury stock related to option exercises | -26.18M |
Payment of acquisition related contingencies | |
Proceeds from stock option exercises | 2.66M |
Excess tax benefit over book expense from stock options exercised | 400K |
Other | |
Net cash flows from financing activities | -34.89M |
Effect of exchange rate changes | -315K |
Net change in cash and cash equivalents for the period | -4.63M |
Cash and cash equivalents, beginning of period | 34.05M |
Cash and cash equivalents, end of period | 29.42M |